Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Inflammation Biomarkers, Oxidative Stress, Cardiometabolic Risk Factors
In brief
Randomized, double-blind, parallel, placebo-controlled clinical trial designed and conducted to evaluate the effect of daily consumption of ginger, on parameters related to inflammation, oxidative stress, and endothelial damage in adults with excess adiposity.
Key facts
- Study ID
- NCT07433998
- Run by
- Javier Marhuenda
- People needed
- 50
- Starts
- 2026-03-01
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2026-03-04
Who can join
Age: 23 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male and female participants.
- Age between 23 and 65 years.
- Body mass index (BMI) > 27.5 kg/m².
- Absence of diagnosed chronic diseases.
- Not receiving pharmacological treatment or dietary supplementation on a regular basis.
- Ability to understand the study procedures and willingness to comply with study requirements.
You may not qualify if…
- Presence of acute or chronic diseases not specified in the inclusion criteria.
- Ongoing chronic pharmacological treatment or active use of dietary supplements.
- Major surgery within the previous three months.
- Current smokers or recent former smokers (less than six months since cessation).
- History of clinically relevant food allergies or eating disorders.
- Concurrent participation in another clinical trial or research study.
- Pregnancy or breastfeeding.
- Following an active weight-loss diet.
- Investigator's judgment of unsuitability for study participation.
Where it is running
- UCAM — Murcia, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.